PDZK1 prevents neointima formation via suppression of breakpoint cluster region kinase in vascular smooth muscle

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Lee, Wan Ru ^a   Sacharidou, Anastasia ^a   Behling Kelly, Erica ^a,e   Oltmann, Sarah C ^a   Zhu, Weifei ^a,f   Ahmed, Mohamed ^a   Gerard, Robert D ^b   Hui, David Y ^c   Abe, Jun Ichi ^d,g   Shaul, Philip W ^a   Mineo, Chieko ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^e Department of Obstetrics Gynecology   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BREAKPOINT CLUSTER REGION PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN PDZK1; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; PDZK1 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CAROTID ARTERY LIGATION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MOUSE; NEOINTIMA; NONHUMAN; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TANDEM AFFINITY PURIFICATION; VASCULAR SMOOTH MUSCLE CELL; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL MOTION; CYTOLOGY; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; INTIMA; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; VASCULAR SMOOTH MUSCLE;

MUS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEINS C-BCR; TUNICA INTIMA;

EID: 84930004624     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124494     Document Type: Article

References (43)

1. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res. 2006; 98: 1352-1364. PMID: 16763172
2. Mineo C, Shaul PW. Functions of scavenger receptor class B, type I in atherosclerosis. Curr Opin Lipidol. 2012; 23: 487-493. doi: 10.1097/MOL.0b013e328357ba61 PMID: 22907331
3. Kocher O, Krieger M. Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr Opin Lipidol. 2009; 20: 236-241. doi: 10.1097/MOL.0b013e32832aee82 PMID: 19421056
4. Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, Krieger M. Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism. J Biol Chem. 2003; 278: 52820-52825. PMID: 14551195
5. Dzau VJ, Braun-Dullaeus RC, Sedding DG. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med. 2002; 8: 1249-1256. doi: 10.1038/nm1102-1249;nm1102-1249 [pii]. PMID: 12411952
6. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008; 28: 812-819. ATVBAHA.107.159327 [pii];doi: 10.1161/ATVBAHA.107.159327 PMID: 18276911
7. Kher N, Marsh JD. Pathobiology of atherosclerosis-a brief review. Semin Thromb Hemost. 2004; 30: 665-672. doi: 10.1055/s-2004-861509 PMID: 15630673
8. De Meyer GR, Bult H. Mechanisms of neointima formation-lessons from experimental models. Vasc Med. 1997; 2: 179-189. PMID: 9546967
9. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, et al. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res. 2006; 98: 63-72. PMID: 16339487
10. Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, et al. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ Res. 2008; 102: 480-487. doi: 10.1161/CIRCRESAHA.107.159079 PMID: 18174467
11. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol. 1997; 17: 2238-2244. PMID: 9351395
12. Resch ZT, Simari RD, Conover CA. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Endocrinology. 2006; 147: 5634-5640. en.2006-0493 [pii];doi: 10.1210/en.2006-0493 PMID: 16959843
13. Hui DY. Intimal hyperplasia in murine models. Curr Drug Targets. 2008; 9: 251-260. PMID: 18336244
14. Zhu B, Kuhel DG, Witte DP, Hui DY. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol. 2000; 157: 1839-1848. PMID: 11106557
15. Basford JE, Moore ZW, Zhou L, Herz J, Hui DY. Smooth muscle LDL receptor-related protein-1 inactivation reduces vascular reactivity and promotes injury-induced neointima formation. Arterioscler Thromb Vasc Biol. 2009; 29: 1772-1778. ATVBAHA.109.194357 [pii];doi: 10.1161/ATVBAHA.109.194357 PMID: 19729608
16. Burckstummer T, Bennett KL, Preradovic A, Schutze G, Hantschel O, Superti-Furga G, et al. An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells. Nat Methods. 2006; 3: 1013-1019. nmeth968 [pii];doi: 10.1038/nmeth968 PMID: 17060908
17. Puig O, Caspary F, Rigaut G, Rutz B, Bouveret E, Bragado-Nilsson E, et al. The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods. 2001; 24: 218-229. doi: 10.1006/meth.2001.1183;S1046-2023(01)91183-1 [pii]. PMID: 11403571
18. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003; 422: 198-207. doi: 10. 1038/nature01511;nature01511 [pii]. PMID: 12634793
19. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999; 20: 3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18〈3551::AID-ELPS3551〉3.0.CO;2-2 [pii];doi: 10.1002/(SICI)1522-2683(19991201)20:18〈3551::AID-ELPS3551〉3.0.CO;2-2 PMID: 10612281
20. Malmberg EK, Andersson CX, Gentzsch M, Chen JH, Mengos A, Cui L, et al. Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3. J Cell Sci. 2004; 117: 5535-5541. jcs.01472 [pii];doi: 10.1242/jcs.01472 PMID: 15494376
21. Aoki K, Barker C, Danthinne X, Imperiale MJ, Nabel GJ. Efficient generation of recombinant adenoviral vectors by Cre-lox recombination in vitro. Mol Med. 1999; 5: 224-231. PMID: 10448644
22. Zeng X, Moore TA, Newstead MW, Hernandez-Alcoceba R, Tsai WC, Standiford TJ. Intrapulmonary expression of macrophage inflammatory protein 1alpha (CCL3) induces neutrophil and NK cell accumulation and stimulates innate immunity in murine bacterial pneumonia. Infect Immun. 2003; 71: 1306-1315. PMID: 12595446
23. Assanasen C, Mineo C, Seetharam D, Yuhanna IS, Marcel YL, Connelly MA, et al. Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling. J Clin Invest. 2005; 115: 969-977. PMID: 15841181
24. Zhu B, Kuhel DG, Witte DP, Hui DY. Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice. Am J Pathol. 2000; 157: 1839-1848. S0002-9440(10)64823-7 [pii];doi: 10.1016/S0002-9440(10)64823-7 PMID: 11106557
25. Kocher O, Comella N, Tognazzi K, Brown LF. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Invest. 1998; 78: 117-125. PMID: 9461128
26. Yesilaltay A, Kocher O, Rigotti A, Krieger M. Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1. Curr Opin Lipidol. 2005; 16: 147-152. PMID: 15767854
27. Laurent E, Talpaz M, Kantarjian H, Kurzrock R. The BCR gene and philadelphia chromosome-positive leukemogenesis. Cancer Res. 2001; 61: 2343-2355. PMID: 11289094
28. Maru Y, Witte ON. The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell. 1991; 67: 459-468. 0092-8674(91)90521-Y [pii]. PMID: 1657398
29. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature. 1993; 366: 643-654. doi: 10.1038/366643a0 PMID: 8259209
30. Braselmann S, McCormick F. Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J. 1995; 14: 4839-4848. PMID: 7588613
31. Alexis JD, Wang N, Che W, Lerner-Marmarosh N, Sahni A, Korshunov VA, et al. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells. Circ Res. 2009; 104: 69-78. CIRCRESAHA.108.188409 [pii];doi: 10.1161/CIRCRESAHA.108.188409 PMID: 19023129
32. Che W, Abe J, Yoshizumi M, Huang Q, Glassman M, Ohta S, et al. p160 Bcr mediates platelet-derived growth factor activation of extracellular signal-regulated kinase in vascular smooth muscle cells. Circulation. 2001; 104: 1399-1406. PMID: 11560856
33. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem. 2003; 278: 9142-9149. PMID: 12511559
34. Schwartz R, Osborne-Lawrence S, Hahner L, Gibson LL, Gormley AK, Vongpatanasin W, et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ Res. 2007; 100: 1452-1459. PMID: 17446434
35. Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, et al. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med. 2001; 7: 853-857. PMID: 11433352
36. Kocher O, Yesilaltay A, Shen CH, Zhang S, Daniels K, Pal R, et al. Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. Biochim Biophys Acta. 2008; 1782: 310-316. doi: 10.1016/j.bbadis.2008.02.004 PMID: 18342019
37. Yesilaltay A, Daniels K, Pal R, Krieger M, Kocher O. Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice. PLoS One. 2009; 4: e8103. doi: 10.1371/journal.pone.0008103 PMID: 19956623
38. Kocher O, Pal R, Roberts M, Cirovic C, Gilchrist A. Targeted Disruption of the PDZK1 Gene by Homologous Recombination. Mol Cell Biol. 2003; 23: 1175-1180. PMID: 12556478
39. Nakamura T, Shibata N, Nishimoto-Shibata T, Feng D, Ikemoto M, Motojima K, et al. Regulation of SRBI protein levels by phosphorylation of its associated protein, PDZK1. Proc Natl Acad Sci U S A. 2005; 102: 13404-13409. 0506679102 [pii];doi: 10.1073/pnas.0506679102 PMID: 16174736
40. Mardones P, Pilon A, Bouly M, Duran D, Nishimoto T, Arai H, et al. Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J Biol Chem. 2003; 278: 7884-7890. doi: 10.1074/jbc.M211627200;M211627200 [pii]. PMID: 12511553
41. Tachibana K, Anzai N, Ueda C, Katayama T, Yamasaki D, Kirino T, et al. Regulation of the human PDZK1 expression by peroxisome proliferator-activated receptor alpha. FEBS Lett. 2008; 582: 3884-3888. S0014-5793(08)00845-4 [pii];doi: 10.1016/j.febslet.2008.10.027 PMID: 18955051
42. Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF, Langdon SP. Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. Gynecol Oncol. 2007; 106: 461-468. S0090-8258(07)00341-1 [pii];doi: 10.1016/j.ygyno.2007.05.009 PMID: 17624412
43. Niemeier A, Kovacs WJ, Strobl W, Stangl H. Atherogenic diet leads to posttranslational down-regulation of murine hepatocyte SR-BI expression. Atherosclerosis. 2009; 202: 169-175. S0021-9150(08) 00255-4 [pii];doi: 10.1016/j.atherosclerosis.2008.04.018 PMID: 18513727